These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 17337201

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L, Bille A, Lal R, Cane P, McLean E, Landau D, Steele J, Spicer J.
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma.
    Edwards JG, Stewart DJ, Martin-Ucar A, Muller S, Richards C, Waller DA.
    J Thorac Cardiovasc Surg; 2006 May; 131(5):981-7. PubMed ID: 16678579
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.
    Mineo TC, Ambrogi V, Pompeo E, Baldi A, Stella F, Aurea P, Marino M.
    Ann Thorac Surg; 2008 May; 85(5):1740-6. PubMed ID: 18442576
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Second surgery for recurrence of malignant pleural mesothelioma after extrapleural pneumonectomy.
    Politi L, Borzellino G.
    Ann Thorac Surg; 2010 Jan; 89(1):207-10. PubMed ID: 20103236
    [Abstract] [Full Text] [Related]

  • 36. Trimodality therapy for malignant pleural mesothelioma.
    Buduhan G, Menon S, Aye R, Louie B, Mehta V, Vallières E.
    Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy.
    Arrossi AV, Lin E, Rice D, Moran CA.
    Am J Clin Pathol; 2008 Nov; 130(5):754-64. PubMed ID: 18854268
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pleurectomy for mesothelioma.
    Brancatisano RP, Joseph MG, McCaughan BC.
    Med J Aust; 1991 Apr 01; 154(7):455-7, 460. PubMed ID: 1706465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.